10x Genomics (0A88) Income Statement
10x Genomics Income Statement
Last quarter (Q2 2026), 10x Genomics's total revenue was $151.04M, a decrease of 12.65% from the same quarter last year. In Q2, 10x Genomics's net income was $-17.93M. See 10x Genomics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 642.82M | $ 610.78M | $ 618.73M | $ 516.41M | $ 490.49M | |
| $ 443.88M | $ 414.48M | $ 409.31M | $ 396.02M | $ 416.40M | |
| $ 554.77M | $ 609.04M | $ 674.64M | $ 563.97M | $ 469.31M | |
| Depreciation and Amortization | $ 43.82M | $ 43.71M | $ 43.62M | $ 33.01M | $ 28.25M |
| $ 3.91M | $ -133.99M | $ -205.11M | $ -128.49M | $ -24.59M | |
| $ -110.89M | $ -194.56M | $ -265.33M | $ -167.94M | $ -52.91M | |
| $ 70.98M | $ 16.86M | $ 16.57M | $ 5.97M | $ -802.00K | |
| $ -39.91M | $ -177.70M | $ -248.76M | $ -161.97M | $ -53.72M | |
| $ -43.54M | $ -182.63M | $ -255.10M | $ -166.00M | $ -58.22M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.35 | $ -1.52 | $ -2.18 | $ -1.46 | $ -0.53 |
| Diluted EPS | $ -0.35 | $ -1.52 | $ -2.18 | $ -1.46 | $ -0.53 |
| Weighted Average Shares Outstanding | 124.75M | 120.45M | 117.17M | 113.86M | 110.35M |
| Weighted Average Shares Outstanding (Diluted) | 124.75M | 120.45M | 117.17M | 113.86M | 110.35M |
Currency in USD
